Table 1.
Selected demographic and disease characteristics according to myosteatosis of stage I–III colon and rectal cancer patients.
| Characteristic | Colon cancer | Rectal cancer | ||||
|---|---|---|---|---|---|---|
| No myosteatosis, n = 32 | Myosteatosis, n = 86 | p value | No myosteatosis, n = 45 | Myosteatosis, n = 64 | p value | |
| Age, № (%) | ||||||
| Less than 65 years | 29 (90.6) | 53 (61.6) | 0.003a | 33 (73.3) | 29 (45.3) | 0.004 b |
| More than 65 years | 3 (9.4) | 33 (38.4) | 12 (26.7) | 35 (54.7) | ||
| Sex, № (%) | ||||||
| Female | 16 (50.0) | 46 (53.5) | 0.736 b | 26 (57.8) | 37 (57.8) | 0.997 b |
| Male | 16 (50.0) | 40 (46.5) | 19 (42.2) | 27 (42.2) | ||
| BMI, median (IQR) | 23.8 (19.6–25.5) | 24.2 (20.9–27.7) | 0.357 c | 25.8 (24.2–27.2) | 25.7 (23.1–29.4) | 0.781 c |
| Weight loss, № (%) | ||||||
| Less than 5% | 9 (28.1) | 18 (20.9) | 0.281 b | 19 (42.2) | 26 (40.6) | 0.976 b |
| More than 5% | 20 (62.5) | 67 (77.9) | 26 (57.8) | 36 (56.3) | ||
| NR | 3 (9.4) | 1 (1.2) | 0 (0.0) | 2 (3.1) | ||
| Alcohol consumption, № (%) | ||||||
| No | 21 (65.6) | 58 (67.4) | 0.858 b | 30 (66.7) | 36 (56.3) | 0.366 b |
| Yes | 9 (28.1) | 27 (31.4) | 15 (33.3) | 26 (40.6) | ||
| NR | 2 (6.3) | 1 (1.2) | 0 (0.0) | 2 (3.1) | ||
| Smoking, № (%) | ||||||
| No | 19 (59.4) | 47 (54.6) | 0.564 b | 25 (55.6) | 28 (43.7) | 0.208 b |
| Yes | 12 (37.5) | 38 (44.2) | 19 (44.2) | 35 (54.7) | ||
| NR | 1 (3.1) | 1 (1.2) | 1 (2.2) | 1 (1.6) | ||
| Charlson Comorbidity Index, № (%) | ||||||
| 2–3 | 26 (81,2) | 27 (31.4) | <0.001 a | 26 (57.8) | 17 (26.6) | 0.001 a |
| ≥4 | 6 (18.8) | 59 (68.6) | 19 (42.2) | 47 (73.4) | ||
| Stage, № (%) | ||||||
| I–II | 10 (31.2) | 34 (39.5) | 0.408 b | 33 (73.3) | 41 (64.1) | 0.325 b |
| III | 22 (68.8) | 52 (60.5) | 11 (24.5) | 21 (32.8) | ||
| TXNXM0 | 0 (0.0) | 0 (0.0) | 1 (2.2) | 2 (3.1) | ||
| Emergency surgery, № (%) | 10 (31.3) | 27 (31.4) | 0.988 b | 2 (4.4) | 0 (0.0) | 0.164 a |
| Neoadjuvant treatment, № (%) | 0 (0.0) | 0 (0.0) | 36 (80.0) | 50 (78.1) | 0.813 b | |
| Adjuvant treatment, № (%) | 31 (96.9) | 63 (73.3) | 0.004 a | 31 (68.9) | 44 (68.8) | 0.988 b |
BMI, body mass index, IQR, interquartile range; SAT, subcutaneous adipose tissue; SD, standard deviation.
a
Fisher’s exact test.
b
Chi-square test.
c
Student’s t test.
Bold was used to highlight values that were statistically significant (< 0.05).